Equol and Vascular Function in Women With Chronic Kidney Disease
Recruiting
Phase 2
Interventional Study
Chronic Kidney Disease (Stage 3-4)
Vascular Function
Cognitive Functions
Cerebrovascular Function
Blood Pressure
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 50 and older
- Sex
- Female
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 74 (estimated)
- Sponsor
- University of Colorado, Denver · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The risk of cardiovascular disease (CVD) is significantly elevated in patients with chronic kidney disease (CKD). Notably, women with CKD commonly experience menstrual disturbances induced by CKD, which may contribute to impaired vascular function and elevated CVD risk. However, most of the literature in nephrology focuses on male patients, and studies on women's vascular health are limited. Estab…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Postmenopausal women
* Aged ≥50 years
* CKD stage 3 or 4 (eGFR with the CKD-EPI 2021 race-free equation: 15-59 mL/min/1.73m2; stable renal function in the past 3 months)
* Low habitual intake of soy (soy-related food intake \< 2 times per week assessed by Soy-Specific Food Fre…
Contacts
Emily Andrews
303-724-7790
CONTACT